casno. : CAS 71-58-9
Medroxyprogesterone is mainly used for dysmenorrhea, functional amenorrhea, functional uterine bleeding, threatened or habitual abortion, endometriosis, treatment of advanced breast cancer, endometrial adenocarcinoma and renal cancer. Large doses can be used as long-acting contraceptives. In addition, the effect is also reflected in that after the endometrium loses its support of estrogen and progesterone during menstruation, it can continue to artificially supplement estrogen or progesterone, especially progesterone, so that the "helpless" endometrium can continue to receive support and maintain the level of continuous thickening, so that the endometrium can grow firmly on the uterine wall, preparing for the implantation of fertilized eggs, and realizing the purpose of delaying menstruation.